From Toad Venom to Drug Development: The Clinical Pharmacology of Mebufotenin (5-MeO-DMT) in Treatment-Resistant Depression

Paper. Likić R, Radanović I, Rkman D et al.. CNS Drugs, 4 Nov 2026.

Tags: Review, 5-MeO-DMT, Depression.

Weekly Science Digest, 30 Oct 2026 to 5 Nov 2026, finding 5: In brief

Detailed clinical pharmacology review of 5-MeO-DMT, including its 30-300x 5-HT1A-over-5-HT2A selectivity and MAO-A-dominated clearance

Read the original

—
Node—
Statuslive
Throughput—